0.05Open0.05Pre Close5 Volume92 Open Interest69.00Strike Price31.00Turnover56.64%IV9.79%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type-0.0381Delta0.0184Gamma1091.57Leverage Ratio-0.0402Theta-0.0003Rho-41.57Eff Leverage0.0066Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet